Federal agency faced obstacles to lower drug prices, memo shows – GLOBAL

May 11, 2023

Health Minister Jean-Yves Duclos was warned that pharmaceutical companies had steadfastly refused to engage on drug-price reforms before he urged an independent federal agency to pause those reforms in favour of more consultation, a 2021 memo shows.

The memo, obtained by the NDP through the access-to-information law and shared with The Canadian Press, is a status report from the acting chair of the Patented Medicine Prices Review Board to the health minister about obstacles they were facing to lowering the price of drugs.

The review board is an arm’s-length federal agency tasked with regulating the cost of patented drugs in Canada to ensure they aren’t excessive, which includes looking at the price of similar medications in other countries.

Read more: https://globalnews.ca/news/9690405/canada-drug-price-reform-memo/

NationTalk Partners & Sponsors Learn More